UK markets open in 3 hours 55 minutes
  • NIKKEI 225

    +64.34 (+0.25%)

    +206.32 (+1.20%)

    -0.32 (-0.39%)

    -8.00 (-0.48%)
  • DOW

    +548.75 (+1.88%)

    +643.36 (+3.71%)
  • CMC Crypto 200

    +15.18 (+3.54%)
  • ^IXIC

    +222.13 (+2.05%)
  • ^FTAS

    +9.79 (+0.26%)

Global Tissue Diagnostics Market Report 2022: Increasing Number of Reagent Rental Agreements Presents Opportunities

·3-min read
Company Logo
Company Logo

Global Tissue Diagnostics Market

Global Tissue Diagnostics Market
Global Tissue Diagnostics Market

Dublin, Sept. 23, 2022 (GLOBE NEWSWIRE) -- The "Tissue Diagnostics Market by Product(Antibodies, Kits, Slide Staining System, Tissue Processing System), Technology(ISH, IHC, Special Staining), Disease(Breast Cancer, NSCLC, Lymphoma), End User (Hospitals, Research Laboratories) - Global Forecast to 2027" report has been added to's offering.

The global Tissue Diagnostics market is growing at a CAGR of 6.6% during and it is expected to reach USD 7.3 billion by 2027 from USD 5.3 billion in 2022, during the forecast period. The expansion of this market is majorly due to rising prevalence of neoplastic cases as well as high demand of oncology screening, However, the lack of skilled professionals is one of the challenge for which may inhibit the growth of this market.

The Slide-Staining Systems in instruments is projected to grow at CAGR of 7.4% from 2022 to 2027

Based on the product, the tissue diagnostics market is classified into tissue diagnostics consumables (Antibodies, Kits, Reagents, Probes) and tissue diagnostics Instruments (Slide-staining Systems, Scanners, Tissue-processing Systems, Other Instruments). The growth of this market is majorly driven by the factors such as benefits of automation, the greater capacity of slide staining systems, and the elimination of manual errors, and delivering high throughput staining capabilities for histology laboratories.

Asia Pacific is estimated to register the highest CAGR during the forecast period.

In this report, the tissue diagnostics market is segmented into four major regional segments, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW). The market in Asia Pacific is projected to register the highest growth rate during the forecast period. The growth in this market is primarily driven by the economic growth in the countries of this region, large population base, the rising prevalence of chronic diseases, the rising standard of living, growing demand for quality medical care, increasing healthcare spending, increasing government initiatives, and rising awareness regarding the use of tissue diagnostic tests

Market Dynamics


  • Rising Prevalence of Cancer

  • Growing Demand for Digital Pathology

  • Increasing Healthcare Expenditure

  • Developing Infrastructure for Cancer Diagnosis

  • Increasing Availability of Reimbursements

  • Growing Private Diagnostics Centers Globally

  • Rising Geriatric Population with Subsequent Growth in Chronic and Infectious Diseases


  • High Degree of Consolidation

  • Opportunities

  • Significant Opportunities in Brics Countries

  • Growing Demand for Personalized Medicines

  • Increasing Number of Clinical Trials Pertaining to Cancer Drugs

  • Emerging Economies to Offer Significant Opportunities to Companies


  • Lack of Skilled Professionals

  • Availability of Refurbished Products

  • Product Failures and Recalls

  • Stringent Regulatory Requirements

  • Lack of Infrastructure and Low Awareness in Middle and Low Income Countries


  • Increasing Number of Reagent Rental Agreements

  • Increasing Usage of AI in Histopathology

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights

5 Market Overview

6 Tissue Diagnostics Market, by Product

7 Tissue Diagnostics Market, by Technology

8 Tissue Diagnostics Market, by Disease

9 Tissue Diagnostics Market, by End-user

10 Tissue Diagnostics Market, by Region

11 Competitive Landscape

12 Company Profiles

13 Appendix

Companies Mentioned

  • 3Dhistech Ltd.

  • Abbott

  • Abcam plc.

  • Agilent Technologies Inc.

  • Amos Scientific Pty Ltd

  • Becton, Dickinson and Company (Bd)

  • Bio Sb

  • Biogenex

  • Cell Signaling Technology, Inc.

  • Cellpath Ltd

  • Dakewei Biotechnology Co. Ltd.

  • Danaher Corporation

  • Diagnostic Biosystems Inc.

  • Diapath S.P.A.

  • F. Hoffmann-La Roche Ltd

  • Histo-Line Laboratories

  • Hologic, Inc

  • Jinhua Yidi Medical Appliance Co. Ltd

  • Kfbio Konfoong Bioinformation Tech Co. Ltd

  • Medite Medical Gmbh

  • Merck Kgaa

  • Rwd Life Science Co. Ltd.

  • Sakura Finetek Japan Co. Ltd.

  • Slee Medical Gmbh

  • Thermo Fisher Scientific Inc.

For more information about this report visit


CONTACT: CONTACT: Laura Wood,Senior Press Manager For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900